Laparoscopic splenectomy: outcome and efficacy for massive and supramassive spleens - 24/03/12
, Zoltán H. Németh, M.D., Ph.D. a, b, Mitchel S. Carter, M.D. a
Corresponding author. Tel.: 973-971-5684; fax: 973-290-7070Abstract |
Background |
Massive and supramassive splenomegaly are relative contraindications to pure laparoscopic splenectomy (LS).
Methods |
A retrospective review of adult patients was conducted for splenectomy occurring from 1999 to 2009. Massive and supramassive spleens were defined as craniocaudad length ≥ 17 cm or weight ≥ 600 g and craniocaudad length ≥ 22 cm or weight ≥ 1,600 g, respectively.
Results |
LS was done for 22 and open splenectomy for 21 patients, of which 12 and 14 were supramassive. Spleen weight and craniocaudad length were comparable. LS was associated with lower blood loss (308 vs 400 mL, P = .24), shorter length of stay (3 vs 4.5 days, P = .054), and similar morbidity (17% vs 14%). Two reoperations and 1 death occurred with open splenectomy. Operative times were longer for LS (195 vs 105 min, P = .008), while the conversion rate was 25%.
Conclusions |
In cases of massive and supramassive splenomegaly, better outcomes are accomplished with LS than open splenectomy, and are comparable to hand-assisted LS.
Le texte complet de cet article est disponible en PDF.Keywords : Laparoscopic splenectomy, Massive splenomegaly, Supramassive splenomegaly, Hand-assisted laparoscopic splenectomy
Plan
Vol 203 - N° 4
P. 517-522 - avril 2012 Retour au numéro
Article précédent
- A randomized, double-blind, placebo-controlled study to assess the effect of recombinant human erythropoietin on functional outcomes in anemic, critically ill, trauma subjects: the Long Term Trauma Outcomes Study
- Fred A. Luchette, Michael D. Pasquale, Timothy C. Fabian, Wayne K. Langholff, Marsha Wolfson
- The script concordance test as a measure of clinical reasoning: a national validation study
- Thamer Nouh, Marylise Boutros, Robert Gagnon, Susan Reid, Kenneth Leslie, David Pace, Dennis Pitt, Ross Walker, Daniel Schiller, Anthony MacLean, Morad Hameed, Paola Fata, Bernard Charlin, Sarkis H. Meterissian
Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?